News about Cancer

Group leaders Jesper B. Andersen and Claus S. Sørensen appointed professors

Group Leader Jesper B. Andersen has been appointed professor in translational hepatology by June 1st 2023. Jesper B. Andersen has been a group leader at BRIC since 2014. The goal of Andersen Group is to unravel the…

Hidden mechanism connects cancer and diabetes

Insulinresistens er normalt noget, man forbinder med type 2-diabetes. Men nu har forskere opdaget det hos kræftpatienter, og det kan have betydning for, hvor hurtigt kræften spreder sig.

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.

‘DNA replication in a tube’ provides new insights into chromatin assembly

Researchers from the Groth group (CPR) and the Mattiroli group (Hubrecht Institute) re-created DNA replication and chromatin assembly in a test tube. They discovered that the crosstalk between these two fundamental…

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Grey hair and wrinkles at an early age led researchers to new treatment for rare cancer

Sarcoma is a rare and complex type of cancer of i.a. the bones and muscles. Now researchers have found a way to predict which sarcoma patients will benefit the most from a potential new treatment.

Previously unknown cell mechanism could help counter cancer and aging

In a new study, researchers from the University of Copenhagen discovered an unknown mechanism of how cells ‘remember’ their identity when they divide – the cells’ so-called epigenetic memory.

Artificial human skin paves the way to new skin cancer therapy

In a new study, researchers have managed to curb skin cancer. The study was conducted on artificial human skin.

Professor Ana Cvejic receives a grant to better understand the interplay between immune cells and cancer

Ana Cvejic, a professor at Biotech Research & Innovation Centre (BRIC), was awarded the DNRF Chair Grant of 10 million DKK over a period of three years to gain knowledge about the interaction of immune and tumor cells.

Ditte Boilesen

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Niels Behrendt receives the NNF Distinguished Innovator Grant

Niels Behrendt, group leader at the Finsen Laboratory, Rigshospitalet/BRIC receives the NNF Distinguished Innovator grant for a project focused on creating test ADC therapeutics.

New project will design 3D microfluidic chips for cancer therapy

Associate Professor Anan Yaghmur has received 2.9 mill DKK from Novo Nordisk Foundation for the project “MICNANO: MICrofluidic synthesis and online characterization of cubosomal and hexosomal NANOcarriers for colorectal…

Now we understand better how cell division works. That puts us a step closer to devising more effective cancer therapies

How does a cell know when to divide? Researchers have found the answer, and it may prove significant to future cancer therapy.

New gene technology is able to predict the effect of treatment on the individual breast cancer patient

How do you know whether breast cancer treatment will be able to cure the individual patient? New gene technology can tell us, and it may prove vital to patients.

Major discovery about mammalian brains surprises researchers

In a new breakthrough to understand more about the mammalian brain, University of Copenhagen researchers have made an incredible discovery. Namely, a vital enzyme that enables brain signals is switching on and off at…

UCPH research fights life-threatening infections in lymphoma patients

Skin lymphoma can lead to severe and even deadly infections. New research from the University of Copenhagen paves the way for prevention.

How cancer cells hide from chemotherapy

Although cancer cells have the ability to divide indefinitely, some appear to have lost this ability and are therefore not sensitive to traditional chemotherapy. New research shows that these cells can still divide and…

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…

Three proteins join forces to spread cancer. Now scientists may destroy them

With cryo-electron microscopy, it is possible to examine proteins more than a 1,000 times smaller than the width of a human hair. Now research using the technology may help develop treatment for some of the deadliest…

Three proteins join forces to spread cancer. Now scientists may destroy them

With cryo-electron microscopy, it is possible to examine proteins more than a 1,000 times smaller than the width of a human hair. Now research using the technology may help develop treatment for some of the deadliest…

Dormant tumour cells use a differentiated cloak to hide from treatments

A group of reNEW scientists has analysed a great number of colon tumours aiming to understand how some tumour cells avoid dying upon treatment with chemotherapies.

Bogdan Cristinoi

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Rationale for combination therapy in acute myeloid leukemia

Acute myeloid leukemia (AML) is a highly heterogeneous disease for which there is an unmet need for improved targeted therapies. In a new study, the Olsen Group and collaborators use phosphoproteomics to devise rational…